RxDoctor Payments DataLook up a doctor →

Margaret Zelasko, MD

Internal Medicine · Muncie, INNPI 1225355613

Payments from drug & device makers

$17,705in general payments, 2019–2025

Across 1,139 payments — averaging $15.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • AstraZeneca$2K
  • Lilly USA, LLC$1K
  • Novo Nordisk$1K
  • Pfizer$971
  • Amgen$865
  • plus $8K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)236$2,628
AstraZeneca119$2,500
Lilly USA, LLC113$1,239
Novo Nordisk75$1,135
Pfizer74$971
Amgen(2 entities)47$865
Arbor Pharmaceuticals, Inc.9$830
GSK72$800
Astellas Pharma US Inc20$464
Boehringer Ingelheim27$439
Novartis20$401
Bayer29$386
Amarin Pharma, Inc.19$351
Otsuka America Pharmaceutical, Inc.15$291
Takeda Pharmaceuticals U.S.A., Inc.20$265
Daiichi Sankyo Inc.13$237
Merck18$213
Johnson & Johnson13$195
Medtronic11$195
Exact Sciences12$190
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)10$184
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$183
E.r. Squibb & Sons, L.L.C.11$176
Azurity Pharmaceuticals, Inc.7$144
Baxter Healthcare2$136
Axsome Therapeutics, Inc.7$125
Biohaven Pharmaceuticals, Inc.7$123
Seqirus USA Inc7$120
Ardelyx, Inc.7$118
Sanofi-aventis U.S. LLC8$111
Teva Pharmaceuticals USA, Inc.7$103
Nabriva Therapeutics, PLC5$93
Esperion Therapeutics, Inc.6$92
Amneal Pharmaceuticals LLC5$82
Lundbeck LLC5$81
Biohaven Pharmaceutical Holding Company Ltd.5$80
Nestle Healthcare Nutrition Inc.5$74
Supernus Pharmaceuticals, Inc.5$73
Axonics, Inc.4$70
Stryker1$67
Biosense Webster, Inc.1$64
Sumitomo Pharma America, Inc.3$56
Almatica Pharma LLC3$53
Ironwood Pharmaceuticals, Inc3$50
Eisai Inc.3$46
Abbott3$44
Inari Medical, Inc.1$39
Phathom Pharmaceuticals, Inc.5$39
Grifols USA, LLC2$39
Dexcom, Inc.2$38
Jazz Pharmaceuticals Inc.2$37
Vanda Pharmaceuticals Inc.2$37
IBSA Pharma Inc.2$34
Genentech USA, Inc.2$29
Terumo Medical Corporation1$27
RGH Enterprises LLC1$26
Kowa Pharmaceuticals America, Inc.2$23
Edwards Lifesciences1$22
Mannkind Corporation1$20
Ironshore Pharmaceuticals Inc.1$19

How this compares

$17,705 in reported general payments places this provider in the 95th percentile of 1,747 internal medicine providers in Indiana.

See all internal medicine providers in Indiana →

Medicare billing

Part B allowed, 2024
$637,374
Medicare patients
1,177
Services billed
20,615

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Muncie

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →